ID   NPC-204
AC   CVCL_A5WV
SY   NPC204
DR   Wikidata; Q107116578
RX   DOI=10.2183/pjab1945.46.453;
RX   PubMed=4377005;
RX   PubMed=7143149;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 24-30 hours (DOI=10.2183/pjab1945.46.453).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C3871; Nasopharyngeal carcinoma
DI   ORDO; Orphanet_150; Nasopharyngeal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
RX   DOI=10.2183/pjab1945.46.453;
RA   Sugano, Haruo
RA   Takada, Mituru
RA   Chen, Hai-Chin
RA   Tu, Shin-Mien
RT   "Presence of herpes-type virus in the culture cell line from a
RT   nasopharyngeal carcinoma in Taiwan.";
RL   Proc. Jpn. Acad., B, Phys. Biol. Sci. 46:453-457(1970).
//
RX   PubMed=4377005; DOI=10.1002/ijc.2910140609;
RA   Suzuki, Masahiro
RA   Hinuma, Yorio
RT   "Evaluation of Epstein-Barr virus-associated nuclear antigen with
RT   various human cell lines.";
RL   Int. J. Cancer 14:753-761(1974).
//
RX   PubMed=7143149; DOI=10.3950/jibiinkoka.85.963;
RA   Tsukuda, Mamoru
RT   "Lymphocyte proliferation assay of the tumor associated antigen
RT   derived from a nasopharyngeal carcinoma cell line (NPC-204).";
RL   Nihon Jibiinkoka Gakkai Kaiho 85:963-970(1982).
//